Ciclesonide: Side Effects, Uses & Monitoring
Seasonal Allergic RhinitisOMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older.
- Data source
- FDA labeling via NIH DailyMed (label 45e1c9d9…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
| Adverse reaction (as reported in labeling) | Reported frequency* |
|---|---|
| Headache | 6% |
| Epistaxis | 4.9% |
| Nasopharyngitis | 3.7% |
| Pharyngolaryngeal pain | 3.4% |
| Ear pain | 2.2% |
*Highest percentage reported for the active moiety across placebo-controlled trial tables in current FDA labeling. Values reflect trial reporting, not your individual risk.
Labeled uses (from FDA prescribing information)
Seasonal Allergic RhinitisOMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. Perennial Allergic RhinitisOMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with perennial allergic rhinitis in adults and adolescents 12 years of age and older.
Conditions associated with Ciclesonide in labeling
Frequently Asked Questions
What is Ciclesonide used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Ciclesonide?
The table above shows adverse reactions and the highest frequencies reported in placebo-controlled trials summarized in current FDA labeling for Ciclesonide. Individual risk varies.
Does Ciclesonide require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Ciclesonide.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.